Yahoo · Oct 28, 2026
Do you qualify for $533 million in prescription drug settlements?
A number of prescription drugs are listed in these generic drug settlements. See how you could claim here.
OTC · SDZNY
Sandoz Group AG
Healthcare · Drug Manufacturers - Specialty & Generic
$101.21
Up+$0.55 (+0.55%)
Updated Nov 5, 2026, 12:43 AM
SID Score
5.0/10
Composite research score
Smart Money
46/100
Neutral
- Market cap
- 32.05B
- P/E ratio
- 140.61
- Dividend yield
- 0.72%
- 52-week range
- — – —
- Volume
- 1.37K
- Avg. volume
- 23.64K
Price performance · SDZNY
SDZNY price history
1M range · 0 trading sessions · Daily adjusted prices
SDZNY does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest SDZNY news
The latest Smart Investors Daily articles mentioning SDZNY.
Stock researchCompany · Overview
Company
Market Activity
Research & News
SDZNY research
Overview
Company profile and research snapshot.
Company profile
SANDOZ GROUP AG S/ADR
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $66.64
- Implied upside
- —
- Analysts
- 18
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 23, 2026 | ROTHSCHILD & CO REDBURN | Buy | — |
| Sep 23, 2026 | JEFFERIES | Buy | — |
| Sep 21, 2026 | BERENBERG | Hold | — |
| Sep 17, 2026 | BAADER EUROPE / ALPHAVALUE | Buy | — |
| Aug 31, 2026 | BNP PARIBAS | Neutral | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 28, 2026
A new Sandoz analysis reveals the next wave of affordable medicines is coming; will Canada be ready?
The next decade will see more than 300 brand-name medicines lose exclusivity or have already become open to competition but have not yet seen market entry, opening the door to a new generation of affordable generic and biosimilar treatments for Canadians. To better understand the scale of this opportunity, Sandoz Canada conducted an in-depth analysis. Aviseo Conseil independently assessed the economic and methodological coherence of the forecasting framework and the overall plausibility of its o
Yahoo · Oct 28, 2026
Sandoz stock falls on sales outlook cut, Q3 miss
Investing.com -- Sandoz Group AG cut its full-year sales forecast while lifting core earnings margin outlook after the company reported worse-than-expected sales for the third quarter. The company’s shares fell nearly 5%.
SeekingAlpha · Oct 28, 2026
Sandoz Group AG (SDZNY) Q3 2026 Sales/Trading Call Transcript
Sandoz Group AG (SDZNY) Q3 2026 Sales/Trading Call October 28, 2026 4:30 AM EDTCompany ParticipantsCraig Marks - Head of Investor RelationsRichard Saynor -...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
